: Expectation of survival of patients receiving HMA + VEN is influenced by pre-treatment comorbidity burden.
Marconi, G., Petracci, E., Lanzarone, G., Vetro, C., Martelli, M.P., Papayannidis, C., et al. (2025). Impact of Pre-Treatment Comorbidity Burden on Survival in Patients Receiving Venetoclax Plus Hypomethylating Agents. AMERICAN JOURNAL OF HEMATOLOGY, 100(4), 708-711 [10.1002/ajh.27591].
Impact of Pre-Treatment Comorbidity Burden on Survival in Patients Receiving Venetoclax Plus Hypomethylating Agents
Marconi, Giovanni
;Papayannidis, Cristina;Martini, Gianluca;Rondoni, Michela;Nanni, Jacopo;Zingaretti, Chiara;Lanza, Francesco;Curti, Antonio;Martinelli, Giovanni
2025
Abstract
: Expectation of survival of patients receiving HMA + VEN is influenced by pre-treatment comorbidity burden.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
AMERIC~1.PDF
accesso aperto
Tipo:
Versione (PDF) editoriale / Version Of Record
Licenza:
Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione
693.5 kB
Formato
Adobe PDF
|
693.5 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
